HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modulation of in vitro growth of murine myeloid leukemia by an autologous substance immunochemically cross-reactive with insulin and antiinsulin serum.

Abstract
Murine myeloid leukemia secretes a substance immunochemically cross-reactive with insulin (SICRI) both in vivo and in serum-free media. High SICRI concentrations in peripheral blood of tumorous animals do not affect circulating glucose levels. In culture, DNA synthesis rate per leukemic cell is proportional to cell density and is reduced by antiinsulin serum. Culture medium conditioned by leukemia cells as well as SICRI affinity purified from this medium stimulate DNA synthesis in cultured leukemia cells. It appears that autocrine stimulation of murine myeloid leukemia can be mediated in part by an insulin-related growth factor.
AuthorsZ Vuk-Pavlović, K Pavelić, S Vuk-Pavlović
JournalBlood (Blood) Vol. 67 Issue 4 Pg. 1031-5 (Apr 1986) ISSN: 0006-4971 [Print] United States
PMID3513865 (Publication Type: Journal Article)
Chemical References
  • Culture Media
  • Immune Sera
  • Insulin
  • Somatomedins
  • DNA
Topics
  • Animals
  • Cell Division
  • Cells, Cultured
  • Cross Reactions
  • Culture Media
  • DNA (biosynthesis)
  • Guinea Pigs
  • Immune Sera (immunology)
  • Insulin (immunology, pharmacology)
  • Leukemia, Myeloid (mortality, pathology)
  • Male
  • Mice
  • Mice, Inbred Strains
  • Molecular Weight
  • Neoplasm Transplantation
  • Somatomedins (immunology, isolation & purification, physiology)
  • Spleen (analysis)
  • Tumor Stem Cell Assay

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: